Glycopeptides (FSH, LH, TSH, prolactin) and glycoproteins in patients with genitourinary cancer.
The present investigation has analyzed 249 patients suffering from urogenital cancer in respect to aberrant concentration of prolactin, TSH, LH and FSH. A simultaneous pattern of acute phase reactants (alpha 1-glycoprotein, alpha 1-antitrypsin, beta 2-glycoprotein and haptoglobin) was related to the content of these hormones. Abnormal results of prolactin and TSH were present in 30% of all patients, whereas frequent aberrations of alpha 1-acid glycoprotein and alpha 1-antitrypsin were detected in 60--80%. Acute phase reactants changed to more pathological values when correlated to elevated prolactin.
D000328:Adult; D000368:Aged; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006020:Glycopeptides / Q000097:blood*; D006023:Glycoproteins / Q000097:blood*; D006242:Haptoglobins / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D009961:Orosomucoid / Q000378:metabolism; D011388:Prolactin / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D014565:Urogenital Neoplasms / Q000097:blood*; D000515:alpha 1-Antitrypsin / Q000378:metabolism
D006020:Glycopeptides; D006023:Glycoproteins; D006242:Haptoglobins; D009961:Orosomucoid; D000515:alpha 1-Antitrypsin; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin